Fundz
Real-time · AI · Cross-signal

SoniVie just raised. Here's exactly what to do next.

Who to reach, what to say, and why now — on SoniVie, plus every funding round, exec hire, and M&A move that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo

Everyone else gives you a piece

✕Crunchbase & PitchBook list the company — No person, no timing, no opener.
✕ZoomInfo & Apollo sell you a contact — No trigger, no reason to reach out now.
✕LinkedIn Sales Navigator shows you people — No real-time signal, no opener.
✕Clay enriches lists you built — No live signal of its own, no who or when.
✕ChatGPT & gen-AI tools answer on a delay — No live data, no verified contact.
Who to contactWhat to sayWhen to reach outWhy now

Only Fundz delivers all four.

Andera Partners Backs $60 Million Series C For Hypertension Medtech Sonivie

PRIVATEJan 15, 2023•over 3 years ago

Amount Raised

$60 Million

Round Type

series c

St. PaulMedicalMedical Device

Investors

Tech WaldOmega FundsSupernova InvestAndera Partners

Description

SoniVie, an Italy and Israel-run med tech seeking to treat hypertension through the use of ultrasound, has closed a $60 million series C round to make headway toward its clinical and regulatory pipeline.

Company Information

Company

SoniVie

Location

St. Paul, Minnesota, United States

About

Founded in 2014 on the achievements of the Therapeutic Intra-Vascular UltraSound-based technology (TIVUS) developed by Cardiosonic for Renal Artery Denervation, Sonivie further developed the technology for Pulmonary Hypertension. TIVUS has been performing clinical trials in both PAH and RDN and has been awarded three Breakthrough Device Designation from the US FDA to treat PAH patients and Uncontrolled and Resistant Hypertension patients, and has obtained a Premarket Application for FDA approval for PAH.

Predictive Intelligence
Strategic

ML-powered predictions for SoniVie's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies.

Watching SoniVie? See every signal — funding, hires, M&A, contracts, sentiment.

Request a demoChoose your plan